FORMALDEHYDE HEALTH HAZARDS AND ITS PRECARCINOGENIC EFFECTS

Autor: Mohamed Oe, Zayet Hh, Said Rm, Sabry Da, Lotfy Bm

Publikováno v: Egyptian Journal of Occupational Medicine. 40:95-108

Introduction: Formaldehyde (FA) is a high-production-volume chemical with a wide array of uses. Recently, it was re-evaluated for its carcinogenic effects and reclassified as humans carcinogen (Group 1) based on sufficient evidence in human and exper

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::91091df3d62109c8ff3d516a0a76c01d
https://doi.org/10.21608/ejom.2016.834

Pediatric sciatic neuropathy presenting as painful leg: A case report and review of literature

Autor: Mohamed Oe Babiker, Ganesh Rao, Manish Prasad, Christopher D. Rittey

Publikováno v: Journal of Pediatric Neurosciences

Introduction: Mononeuropathies, in general, are very uncommon in childhood. Sciatic neuropathy (SN) is probably underappreciated in childhood and likely to represent nearly one quarter of childhood mononeuropathies. Materials and Methods: We present

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8261d02b1f969f5c6c7ad6ae03c65a
http://europepmc.org/articles/PMC3783730

Fifteen-minute consultation: when is a seizure not a seizure? Part 2, the older child.

Autor: Babiker, Mohamed O. E., Prasad, Manish, Babiker, Mohamed Oe

Publikováno v: Archives of Disease in Childhood -- Education & Practice Edition; Dec2015, Vol. 100 Issue 6, p295-300, 6p

Loss of tubulin deglutamylase CCP1 causes infantile‐onset neurodegeneration.

Autor: Shashi, Vandana, Magiera, Maria M, Klein, Dennis, Zaki, Maha, Schoch, Kelly, Rudnik‐Schöneborn, Sabine, Norman, Andrew, Lopes Abath Neto, Osorio, Dusl, Marina, Yuan, Xidi, Bartesaghi, Luca, De Marco, Patrizia, Alfares, Ahmed A, Marom, Ronit, Arold, Stefan T, Guzmán‐Vega, Francisco J, Pena, Loren DM, Smith, Edward C, Steinlin, Maja, Babiker, Mohamed OE

Publikováno v: EMBO Journal; Dec2018, Vol. 37 Issue 23, pN.PAG-N.PAG, 1p, 5 Diagrams

The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.

Autor: Smits B; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Goldacker S; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Seneviratne S; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom., Malphettes M; Département d'Immunologie, Hôpital Saint-Louis, Paris, France., Longhurst H; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom., Mohamed OE; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom., Witt-Rautenberg C; Division of Rheumatology and Clinical Immunology, Department of Medicine IV, University of Munich, Munich, Germany., Leeman L; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom., Schwaneck E; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany; Rheumatology/Clinical Immunology Asklepios Klinik Altona, Hamburg, Germany., Raymond I; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France., Meghit K; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France., Uhlmann A; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinical Trials Unit, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Winterhalter C; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Clinical Trials Unit, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., van Montfrans J; Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands., Klima M; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Workman S; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom., Fieschi C; Département d'Immunologie, Hôpital Saint-Louis, Paris, France., Lorenzo L; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom., Boyle S; Clinical Immunology, Royal Papworth Hospital, Cambridge, United Kingdom., Onyango-Odera S; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom., Price S; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom., Schmalzing M; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany., Aurillac V; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France., Prasse A; Department of Respiratory Medicine, Medizinische Hochschule Hannover, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease, Deutsches Zentrum für Lungenforschung, Hannover, Germany., Hartmann I; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Meerburg JJ; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Kemner-van de Corput M; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Tiddens H; Department of Pediatric Respiratory Medicine, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Radiology, Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands., Grimbacher B; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Center for Infection Research, Satellite Center Freiburg, Freiburg, Germany; Resolving Infection Susceptibility, Cluster of Excellence 2155 to Hanover Medical School, Satellite Center Freiburg, Freiburg, Germany; Centre for Integrative Biological Signalling Studies, Albert-Ludwigs University, Freiburg, Germany., Kelleher P; Department of Infectious Diseases, Imperial College London, London, United Kingdom., Patel SY; Department of Clinical Immunology, Oxford University Hospitals National Health Service Foundation Trust, United Kingdom; National Institute for Health and Care Research Biomedical Research Unit, University of Oxford, United Kingdom., Korganow AS; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France., Viallard JF; Department of Internal Medicine, Centre Hospitalier Universitaire of Bordeaux, Bordeaux, France., Tony HP; Rheumatology/Clinical Immunology, University Hospital of Wuerzburg, Wuerzburg, Germany., Bethune C; Peninsula Immunology and Allergy Service, University Hospitals Plymouth, Plymouth, United Kingdom., Schulze-Koops H; Rheumatology/Clinical Immunology Asklepios Klinik Altona, Hamburg, Germany., Witte T; Department for Rheumatology and Immunology, Hannover Medical School, Hannover, Germany., Huissoon A; West Midlands Primary Immunodeficiency Centre, Birmingham Heartlands Hospital, Birmingham, United Kingdom., Baxendale H; Clinical Immunology, Royal Papworth Hospital, Cambridge, United Kingdom., Grigoriadou S; Department of Immunology and Department of Haemato-Oncology, Barts Health National Health Service Trust, The Royal London Hospital, London, United Kingdom., Oksenhendler E; Département d'Immunologie, Hôpital Saint-Louis, Paris, France; Department of Clinical Immunology and Université de Paris, Paris, France., Burns SO; Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom; Institute of Immunity and Transplantation, University College London, London, United Kingdom., Warnatz K; Division of Immunodeficiency, Department of Rheumatology and Clinical Immunology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Center for Chronic Immunodeficiency, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Electronic address: klaus.warnatz@uniklinik-freiburg.de.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Aug; Vol. 152 (2), pp. 528-537. Date of Electronic Publication: 2022 Dec 29.